CI vs MET
CI: Global health services company combining pharmacy benefits, specialty care, and medical insurance to improve affordability, transparency, and health outcomes across 185 million customer relationships. MET: A global insurance and asset management powerhouse leveraging a massive institutional investment portfolio and a leading U.S. group benefits platform to deliver long-term financial security.
Side-by-side fundamentals
| Metric | CI | MET | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $284.85 | $93.27 | |
| Market cap as of 2026-07-23 | $76.9B | $60.0B | |
| P/E as of 2026-07-23 | 12.24 | 16.59 | CI lower |
| PEG as of 2026-07-23 | 1.50 | 1.43 | MET lower |
| Net margin as of 2026-07-23 | +2.3% | +4.7% | MET higher |
| Gross margin as of 2026-07-23 | +9.2% | n/a | |
| Operating margin as of 2026-07-23 | +3.4% | +7.4% | MET higher |
| ROE as of 2026-07-23 | +15.2% | +12.9% | CI higher |
| ROA as of 2026-07-23 | +4.0% | +0.5% | CI higher |
| Debt / equity as of 2026-07-23 | 0.73 | 0.73 | MET lower |
| Revenue growth (YoY) as of 2026-07-23 | +8.8% | +5.3% | CI higher |
| Revenue CAGR (3y) SEC XBRL | +15.0% | +3.9% | CI higher |
| Dividend yield as of 2026-07-23 | +2.1% | +2.5% | MET higher |
| Dividend streak (yrs) SEC XBRL | 5 | 5 | Tie |
| Beta as of 2026-07-23 | 0.32 | 0.77 | |
| 1-year return as of 2026-07-22 close | -1.5% | +20.3% | MET higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.